Overview

Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

Status:
Completed
Trial end date:
2021-06-18
Target enrollment:
Participant gender:
Summary
Clinical Trial to Evaluate the Efficacy and Safety of CKD-386
Phase:
Phase 3
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Antihypertensive Agents
Hypolipidemic Agents